Literature DB >> 6614430

Pancuronium requirements during hypothermic cardiopulmonary bypass in man.

M E Futter, D G Whalley, J E Wynands, D R Bevan.   

Abstract

Eight patients were studied to determine the changes in pancuronium requirements during hypothermic cardiopulmonary bypass. They were anaesthetised with fentanyl as the principal agent, ventilated with oxygen and the neuromuscular junction was monitored using train-of-four stimulation. After a bolus dose of pancuronium an infusion was used to maintain the first twitch of the train-of-four at 5-15 per cent of control. Before bypass the mean pancuronium infusion rate was 0.52 (SD 0.16) micrograms/kg/min. There was a small, brief increase in requirement with the initiation of bypass to 0.62 (SD 0.38) micrograms/kg/min, which was followed by a decrease of more than 80 per cent during hypothermia to 0.08 (SD 0.03) micrograms/kg/min. Rewarming was associated with a rapid increase in requirement to 0.64 (SD 0.17) micrograms/kg/min, which decreased to 0.33 (SD 0.23) micrograms/kg/min when normothermia was re-established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614430     DOI: 10.1177/0310057X8301100306

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

1.  Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.

Authors:  P McDonagh; J Y Dupuis; M Curran; J Kitts; J E Wynands
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

2.  Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine.

Authors:  J M Wierda; P J van der Starre; A H Scaf; W D Kloppenburg; J H Proost; S Agoston
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

3.  The effects of shivering on oxygen consumption and carbon dioxide production in patients rewarming from hypothermic cardiopulmonary bypass.

Authors:  F E Ralley; J E Wynands; J G Ramsay; F Carli; R MacSullivan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

Review 4.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update.

Authors:  W A Buylaert; L L Herregods; E P Mortier; M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.